Single iron infusion improved exercise capacity in people with the most common form of heart failure

A clinical trial published in Circulation found that a single intravenous iron infusion significantly improves exercise capacity in patients with heart failure with preserved ejection fraction (HFpEF). The study suggests that iron deficiency is a treatable factor in managing the physical limitations of this condition.
Why it matters
This finding offers a potential new standard of care for a common and debilitating condition that currently lacks effective treatment options.
edited by Gaby Clark , reviewed by Andrew Zinin
This article has been reviewed according to Science X's editorial process and policies . Editors have highlighted the following attributes while ensuring the content's credibility:
Add to Preferred Sources Credit: Pixabay/CC0 Public Domain A new study by investigators from the Mass General Brigham Heart and Vascular Institute found that a single iron infusion improved exercise capacity in people with heart failure with preserved ejection fraction (HFpEF) and iron deficiency. The findings suggest that replenishing iron could help address the physical limitations associated with this condition. Results were presented at the 2026 American Heart Association Scientific Sessions and published simultaneously in Circulation .
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in